Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.

Name: Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.
License: Public Domain

Novartis

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

essential hypertension

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 474850
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.